Catalyst fails to mollify Bernie Sanders over rare-disease drug price- STAT

Catalyst fails to mollify Bernie Sanders over rare-disease drug price- STAT

STAT Plus: Catalyst fails to mollify an angry Bernie Sanders over the price of its rare disease drug

By ED SILVERMAN

BILL PUGLIANO/GETTY IMAGES

The pricing has become an issue in part because Catalyst did not invent the active ingredient, but licensed what became Firdapse from another company.

READ MORE